Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOSONICS LIMITED Director's Dealing 2012

Nov 12, 2012

65405_rns_2012-11-12_6f8480a6-242b-4afb-9592-07d979506f58.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Nanosonics Limited ABN 11 095 076 896

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Ronald Peter Weinberger
Date of last notice 6 September 2012

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest a) Indirect Interest
b) Direct Interest
c) Indirect Interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
a) Shares held under the Nanosonics
Deferred Employee Share Plan
b) Fully Paid Shares
c) Options
Date of change 12 November 2012
No. of securities held prior to change a) 134,772 Shares held under the
Nanosonics
Deferred
Employee
Share Plan
b) 693,930 Fully Paid Shares
c) 30,970
Options
held
in
the
Nanosonics Employee Share Option
Plan
Class a) Ordinary Shares
b) Ordinary Shares
c) Options
Number acquired 1) 29,881 Options
2) 1,220,000 Performance Rights
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
NIL
No. of securities held after change a) 134,772 (Indirect) Shares held in the
Nanosonics
Deferred
Employee
Share Plan
b) 693,930 (Direct) Fully Paid Shares
c) 60,851 (Indirect) Options held in the
Nanosonics Employee Share Option
Plan
d) 1,220,000
(Indirect)
Performance
Rights held in the Nanosonics
Employee Share Option Plan.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
1) Issue of Options under the terms and
conditions
of
the
Nanosonics
Employee Share Option Plan
2) Issue of Performance Rights under
the terms and conditions of the
Nanosonics Employee Share Option
Plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 259] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
If prior written clearance was provided, on what date was this
provided?

Director: Dr Ronald Peter Weinberger Date 13 November 2012

  • See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002